Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 63 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 9517241

    Amelioration of intestinal fibrosis and treatment of Crohn's disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  2. US 9511020

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted

  3. US 9512224

    Use of semaphorin-4D binding molecules for treatment of atherosclerosis

    VACCINEX, INC. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted

  4. US 9504745

    Compositions and methods for cancer treatment using targeted carbon nanotubes

    The Board of Regents of the University of Oklahoma · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted

  5. US 9498468

    Rhinitis treatment regimens

    Pharmaceutical Design, LLC · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  6. US 9499494

    Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis

    Northwestern University · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  7. US 9498544

    Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

    Tissue Regeneration Therapeutics Inc. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  8. US 9498511

    Methods related to the treatment of neurodegenerative and inflammatory conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  9. US 9498445

    Pharmaceutical compositions for the treatment of Helicobacter pylori

    RedHill Biopharma Ltd. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  10. US 9492405

    Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  11. US 9493432

    Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders

    Takeda Pharmaceutical Company Limited · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  12. US 9492433

    Pharmaceutical composition for the treatment of Duchenne muscular dystrophy

    Summit Corporation Plc · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  13. US 9493552

    Therapeutic biologic for treatment of hepatocellular carcinoma

    China Synthetic Rubber Corporation · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  14. US 9487786

    Immunosuppression compound and treatment method

    Sarepta Therapeutics, Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  15. US 9486456

    Treatment of esophageal motility disorder using sepiapterin, tetrahydrobiopterin and derivatives thereof

    The Board of Regents of the University of Texas System · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  16. US 9487575

    Compositions and methods for treatment of gynecologic cancers

    The Regents of the University of California · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  17. US 9487753

    Compositions of adult disc stem cells and methods for the treatment of degenerative disc disease

    DiscGenics, Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  18. US 9480725

    Fermented wheat germ proteins (FWGP) for the treatment of cancer

    The Regents of the University of California · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  19. US 9481692

    Heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  20. US 9476047

    RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

    Arrowhead Pharmaceuticals, Inc. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  21. US 9475871

    Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

    Five Prime Therapeutics, Inc. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  22. US 9474743

    Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  23. US 9474793

    Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  24. US 9475832

    Phosphonates with reduced toxicity for treatment of viral infections

    The Regents of the University of California · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.